Two Sigma Investments
CTOR

Two Sigma Investments’s Citius Oncology CTOR Stock Holding History

Two Sigma Investments’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,515
Closed -$23.5K – 4991
2025
Q4 		$23.5K Buy
+23,515
New +$33.7K ﹤0.01% 3986
2024
Q1 		– Sell
-150,000
Closed -$1.64M – 3437
2023
Q4 		$1.64M Hold
150,000
– – ﹤0.01% 1751
2023
Q3 		$1.62M Hold
150,000
– – ﹤0.01% 1574
2023
Q2 		$1.58M Hold
150,000
– – ﹤0.01% 1638
2023
Q1 		$1.55M Hold
150,000
– – ﹤0.01% 1577
2022
Q4 		$1.52M Buy
+150,000
New +$1.52M ﹤0.01% 1462

Other funds holding CTOR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's CTOR Position: Q1 2026 in Review

Two Sigma Investments sold out of Citius Oncology (CTOR) in Q1 2026, closing a stake of 23,515 shares — an estimated $23.5K sold.

Two Sigma Investments first reported a position in CTOR in Q4 2022 and held it in 6 quarters. The position peaked at $1.64M in Q4 2023. 14 funds tracked by Wall St. Rank hold CTOR as of Q1 2026.

  • Two Sigma Investments reported no remaining Citius Oncology position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 23,515 Citius Oncology shares in Q1 2026, an estimated $23.5K.
  • Two Sigma Investments first reported a position in Citius Oncology in Q4 2022 and held it in 6 quarters.
  • Two Sigma Investments's Citius Oncology position peaked at $1.64M in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.